A Study to Assess the Efficacy and Safety of ASP1941 in Japanese Type 2 Diabetes Patients
A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 130 participants.
Also called NCT01057628
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 130 participants
- Sponsor
- Registry
-
NCT01057628
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Japan
- Registry status
- Completed
Technical summary
Registry record NCT01057628. Randomized; quadruple masking; primary purpose treatment. Start 2010-01-13 (actual); primary completion 2010-11-06 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- A Study to Assess the Efficacy and Safety of ASP1941 in Japanese Type 2 Diabetes Patients
- Condition
- Type 2 Diabetes Mellitus
- Intervention (Drug)
- ipragliflozin
- Intervention (Drug)
- placebo
- Lead sponsor
- Astellas Pharma Inc
Record details
- Record id
cardio:ct-nct01057628- Content hash
5989f2cdb31817c2c131ef199320b471523c162fc0ab0728f13646b32cd8efa1